📊 AMRZ Key Takeaways
Is Amrize Ltd (AMRZ) a Good Investment?
Amrize demonstrates solid financial health with strong liquidity (1.64x current ratio), manageable leverage (0.40x debt/equity), and robust cash generation (1.4B free cash flow). However, growth is stalling with near-flat revenue and net income growth (~0.9% and 0.3% YoY), while diluted EPS declined 7.0% despite absolute earnings growth, signaling shareholder dilution concerns.
Amrize shows solid core fundamentals with healthy profitability, strong free cash flow generation, and a conservative balance sheet. Margins are robust for a heavy industrial business, and liquidity plus interest coverage indicate good financial resilience. The main limitation is muted top-line and net income growth, with diluted EPS declining despite stable earnings, which suggests only moderate growth quality today.
Why Buy Amrize Ltd Stock? AMRZ Key Strengths
- Strong operating cash flow of 2.2B with 12% FCF margin demonstrates efficient core business operations
- Conservative capital structure with 0.40x debt/equity and 8.8x interest coverage provides financial stability
- Healthy profitability with 25.7% gross margin and 10% net margin in cyclical cement industry
- Adequate liquidity with 1.64x current ratio and 1.9B cash position
- Strong profitability with 25.7% gross margin, 16.1% operating margin, and 10.0% net margin
- Healthy financial position supported by 1.64x current ratio, 0.40x debt-to-equity, and 8.8x interest coverage
- Good cash generation with $2.21B operating cash flow and $1.42B free cash flow, equal to a 12.0% FCF margin
AMRZ Stock Risks: Amrize Ltd Investment Risks
- Revenue growth stalled at 0.9% YoY indicating market saturation or competitive pressures in cement sector
- Diluted EPS declining 7.0% YoY despite modest net income growth suggests share dilution and potential capital allocation inefficiency
- Return on equity of only 8.9% and ROA of 4.9% below cost of capital expectations for a stable industrial company
- Subdued net margin expansion despite operational leverage, signaling pricing power limitations or rising input costs
- Revenue growth of 0.9% and net income growth of 0.3% indicate limited current growth momentum
- Diluted EPS fell 7.0% year over year despite stable net income, pointing to possible dilution or weaker per-share earnings quality
- ROE of 8.9% and ROA of 4.9% are respectable but not standout, limiting evidence of high-return compounding
Key Metrics to Watch
- Revenue growth trajectory and volume trends in core cement markets
- Net income growth relative to share dilution (EPS conversion efficiency)
- Free cash flow conversion and capital allocation decisions
- Operating margin expansion amid input cost inflation
- Return on equity improvement and capital efficiency
- Diluted EPS trend relative to net income growth
- Revenue growth and free cash flow margin sustainability
Amrize Ltd (AMRZ) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Amrize Ltd presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
AMRZ Profit Margin, ROE & Profitability Analysis
AMRZ vs Materials Sector: How Amrize Ltd Compares
How Amrize Ltd compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Amrize Ltd Stock Overvalued? AMRZ Valuation Analysis 2026
Based on fundamental analysis, Amrize Ltd has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Amrize Ltd Balance Sheet: AMRZ Debt, Cash & Liquidity
AMRZ Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Amrize Ltd's revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $1.73 reflects profitable operations.
AMRZ Revenue Growth, EPS Growth & YoY Performance
AMRZ Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $3.4B | $545.0M | $0.98 |
| Q2 2025 | $3.2B | $342.0M | $0.62 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Amrize Ltd Dividends, Buybacks & Capital Allocation
AMRZ SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Amrize Ltd (CIK: 0002035989)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AMRZ
What is the AI rating for AMRZ?
Amrize Ltd (AMRZ) has a Combined AI Rating of BUY from Claude (HOLD) and ChatGPT (BUY) with 70% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AMRZ's key strengths?
Claude: Strong operating cash flow of 2.2B with 12% FCF margin demonstrates efficient core business operations. Conservative capital structure with 0.40x debt/equity and 8.8x interest coverage provides financial stability. ChatGPT: Strong profitability with 25.7% gross margin, 16.1% operating margin, and 10.0% net margin. Healthy financial position supported by 1.64x current ratio, 0.40x debt-to-equity, and 8.8x interest coverage.
What are the risks of investing in AMRZ?
Claude: Revenue growth stalled at 0.9% YoY indicating market saturation or competitive pressures in cement sector. Diluted EPS declining 7.0% YoY despite modest net income growth suggests share dilution and potential capital allocation inefficiency. ChatGPT: Revenue growth of 0.9% and net income growth of 0.3% indicate limited current growth momentum. Diluted EPS fell 7.0% year over year despite stable net income, pointing to possible dilution or weaker per-share earnings quality.
What is AMRZ's revenue and growth?
Amrize Ltd reported revenue of $11.8B.
Does AMRZ pay dividends?
Amrize Ltd does not currently pay dividends.
Where can I find AMRZ SEC filings?
Official SEC filings for Amrize Ltd (CIK: 0002035989) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AMRZ's EPS?
Amrize Ltd has a diluted EPS of $2.14.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AMRZ a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Amrize Ltd has a BUY rating with 70% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is AMRZ stock overvalued or undervalued?
Valuation metrics for AMRZ: ROE of 8.9% (sector avg: 14%), net margin of 10.0% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy AMRZ stock in 2026?
Our dual AI analysis gives Amrize Ltd a combined BUY rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is AMRZ's free cash flow?
Amrize Ltd's operating cash flow is $2.2B, with capital expenditures of $788.0M. FCF margin is 12.0%.
How does AMRZ compare to other Materials stocks?
Vs Materials sector averages: Net margin 10.0% (avg: 10%), ROE 8.9% (avg: 14%), current ratio 1.64 (avg: 1.6).